Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to using science-based innovation to address some of society's most challenging healthcare issues. Only by working together can we improve outcomes for patients and change the practice of medicine.
![Young patients waiting outside hospital in Rwanda Young patients waiting outside hospital in Rwanda](/sites/novartis_id/files/styles/cta_image/public/2021-11/young-patients-waiting-outside-hospital-in-rwanda.jpg.webp?itok=hYcet55F)
The Novartis Commitment to Patients and Caregivers
We recognize the importance of patients and caregivers understanding what they can expect from Novartis.
![inflammation-visual-essay-hero-image inflammation-visual-essay-hero-image](/sites/novartis_id/files/styles/cards_50_50/public/2021-07/inflammation-visual-essay-hero-image.jpg.webp?itok=3-ok-1Ql)
Global Therapeutic Focus Areas
Our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples’ lives.
![A hand with a pill tray A hand with a pill tray](/sites/novartis_id/files/styles/cards_50_50/public/2021-11/hand-with-a-pill-tray.jpg.webp?itok=c8myz_jL)
Global Products
Learn more about treatments currently offered by Novartis Innovative Medicines, Sandoz and Advanced Accelerator
![lung-cancer-hero-image lung-cancer-hero-image](/sites/novartis_id/files/styles/cards_50_50/public/2021-07/lung-cancer-hero-image.jpg.webp?itok=6FBtgKTG)
Patient Resources
Novartis believes that medicines should be available to all who need them. We have a variety of programs to help support patients and make it easier for them to access their medicines.
![Q2_HP Hero image-edited Q2_HP Hero image-edited](/sites/novartis_id/files/styles/cards_50_50/public/2021-07/Q2_HP%20Hero%20image-edited.jpg.webp?itok=yuHtV6M5)
Adverse Event Reporting
Reporting suspected side effects of the medicinal product is important to Novartis.